Share this article Share this article CENTER VALLEY, Pa., Jan. 19, 2021 /PRNewswire/ -- Aesculap has been awarded a contract with Vizient that offers state-of-the-art neurosurgical technology at enhanced savings to Vizient member hospitals. The contract includes Cerebral Spinal Fluid (CSF) Management and Dural Repair and Neuro Critical Care product categories. Vizient's diverse membership and customer base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute healthcare providers and represents more than $100 billion in annual purchasing volume. As a result of the award, Vizient members will now have access to contracted pricing for all of Aesculap's fixed and programmable hydrocephalus shunts, including the new